RE

Rolf Ehrnström

Partner Ventac Partners

Sweden

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Board Member

    2024

  • Member Board of Directors

    2021

  • Member Board of Directors

    2021

  • CEO and Owner

    2013

    Consultant Company providing professional technical, scientific and commercial advising and services to Life Science companies, Venture Capital, Private Equity and Universities. Primary focus is on all aspects life scienece diagnostics and drug-diagnostic interface.

  • Partner

    2012

    WE BRING INNOVATION AND CHANGE TO OUR CLIENTS With offices across United States , Europe and Asia and with our multi-disciplinary pharma, biotech and medtech team, we bring global solutions to our clients, delivered locally. We provide the management skills required to take innovative science from the lab to the market We team up with clients in the biotechnology, pharma and medtech sectors to identify high-value opportunities, address critical challenges and foster profitable businesses worldwide. We provide critical IP, clinical, regulatory, business and financial solutions to the client through our international partner team

2021 - 2023

  • Member Board of Directors

    2021 - 2023

2013 - 2022

  • Chief Scientific Officer

    2013 - 2022

  • Science advisor

    2013 - 2015

2005 - 2012

  • Chief Scientific Officer

    2010 - 2012

  • CVP R&D

    2005 - 2010